Close Menu

NEW YORK – Oxford Nanopore Technologies said on Friday that its LamPore SARS-CoV-2 sequencing test has obtained the CE mark for use with the GridIon platform.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.